UCB, BE0003739530

UCB stock heads into the open after a 1.1 percent drop

Published on 09/10/2026 at 07:33 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

At the close on September 9, 2026, UCB stock finished at EUR 204.60 in Brussels, down 1.1 percent, while the BEL 20 slipped back below the 5,700 point mark. Sector moves and oil prices framed the session ahead of today’s trade.

Moderner Biopharma-Forschungscampus mit Glasgebäuden und Laborpersonal in Brüssel bei Tageslicht
UCB S.A. mit ISIN BE0003739530 zeigt modernen Forschungscampus in Brüssel mit Laborpersonal in Glasgebäuden, Illustration mit AI erstellt.

UCB stock closed at EUR 204.60 on Euronext Brussels on September 9, 2026, losing 1.1 percent from the previous session. The move came as the BEL 20 index temporarily fell back below the 5,700 point threshold in a weaker Brussels market.

September 9, 2026 in numbers

UCB SA (ISIN BE0003739530) ended the September 9, 2026 session at EUR 204.60 on Euronext Brussels, down 1.11 percent compared with the prior close, according to Brussels market data noted by DHnet. Within the same session, the BEL 20 index slipped below the 5,700 point level as oil prices moved higher, underscoring a softer tone across several large caps in Brussels, including UCB.

As DHnet reported, UCB’s decline on September 9, 2026 came alongside modest losses in other index constituents, indicating that the stock tracked the broader market rather than a company specific shock. The quantified comparison shows UCB down slightly more than the BEL 20 index, which itself retreated as energy related names reacted to firming oil prices in the region.

Today’s drivers to watch

On September 10, 2026, investors face a new session for UCB with the prior day’s Brussels performance and the BEL 20 backdrop still in view. As DHnet highlighted on September 9, 2026, UCB announced that US regulators have granted an accelerated review procedure for its drug Cimzia, a regulatory step that can shape sentiment around the company’s pipeline today. Broader European equity moves and any follow up commentary on regulatory timelines for Cimzia may therefore influence how UCB trades in the upcoming Brussels session.

Disclaimer...

en | BE0003739530 | UCB | boerse | 70079429 | bgmi